PWAM
SBBP

Park West Asset Management’s Strongbridge Biopharma plc. SBBP Stock Holding History

Park West Asset Management’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-76,446
Closed -$239K – 93
2019
Q2 		$239K Sell
76,446
-1,246,213
-94% -$4.58M 0.01% 84
2019
Q1 		$6.59M Sell
1,322,659
-202,949
-13% -$999K 0.29% 66
2018
Q4 		$6.83M Sell
1,525,608
-50,000
-3% -$244K 0.34% 61
2018
Q3 		$7.64M Buy
1,575,608
+493,808
+46% +$2.53M 0.28% 65
2018
Q2 		$6.49M Buy
1,081,800
+300,000
+38% +$2.19M 0.24% 81
2018
Q1 		$6.92M Buy
+781,800
New +$5.85M 0.31% 64

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Park West Asset Management's SBBP Position: Q3 2019 in Review

Park West Asset Management sold out of Strongbridge Biopharma plc. (SBBP) in Q3 2019, closing a stake of 76,446 shares — an estimated $239K sold.

Park West Asset Management first reported a position in SBBP in Q1 2018 and held it in 6 quarters. The position peaked at $7.64M in Q3 2018. 54 funds tracked by Wall St. Rank hold SBBP as of Q3 2019.

  • Park West Asset Management reported no remaining Strongbridge Biopharma plc. position as of Q3 2019 after selling out during the quarter.
  • Park West Asset Management sold 76,446 Strongbridge Biopharma plc. shares in Q3 2019, an estimated $239K.
  • Park West Asset Management first reported a position in Strongbridge Biopharma plc. in Q1 2018 and held it in 6 quarters.
  • Park West Asset Management's Strongbridge Biopharma plc. position peaked at $7.64M in Q3 2018.
  • 54 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q3 2019.

Based on Park West Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.